Direct costs of relapses in patients with relapsing-remitting multiple sclerosis

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis

Introduction: Effective treatments that reduce relapses can diminish the impact on MS costs in the long-term. This study aims to estimate direct costs of RRMS relapses in Catalonia (Spanish region). Methods: Multi-centre, prospective, cross-sectional observational study with retrospective data colle...

Full description

Bibliographic Details
Main Authors: V. Casado, I. Bonaventura, L. Brieva, S. Martínez-Yélamos, G. Martín, S. Presas-Rodriguez, M. Hervas, J.J. Hernández, E. Munteis, A. Escartin, L. Gubieras, M.A. Mañé-Martínez, L. Ramió-Torrentà
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Neurology Perspectives
Subjects:
Esclerosis múltiple remitente-recurrente
Costes directos de los brotes
Fármaco modificador de la enfermedad
Estudio observacional
Cataluña
España
Online Access:http://www.sciencedirect.com/science/article/pii/S2667049621000387

Internet

http://www.sciencedirect.com/science/article/pii/S2667049621000387

Similar Items